ArticleWiener klinische Wochenschrift2017

Abiraterone for castration-resistant prostate cancer: adherence, survival and hospitalization : Analysis of a medical claims database.

Badereddin Mohamad Al-Ali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.